Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 16, 2026

Mar. 16, 2026

Austin Natural Mattress Celebrates 26 Years as Central Texas Leader in Organic and Non-Toxic Sleep Products

GlobeNewswire

Mar. 16, 2026

Pattern Discovers New microRNA Drug for Treatment of Glioblastoma Cancer

GlobeNewswire

Mar. 16, 2026

Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

GlobeNewswire

Mar. 16, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 16, 2026

Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance

GlobeNewswire

Mar. 16, 2026

CMR Surgical Advances Physical AI to Support the Future of Robotic Surgery with NVIDIA

GlobeNewswire

Mar. 16, 2026

iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

GlobeNewswire

Mar. 16, 2026

LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC

GlobeNewswire

Mar. 16, 2026

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire

Mar. 16, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

GlobeNewswire

Mar. 16, 2026

Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results

GlobeNewswire

Mar. 16, 2026

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 16, 2026

Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

GlobeNewswire

Mar. 16, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 16, 2026

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Mar. 16, 2026

Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 16, 2026

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 16, 2026

Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

GlobeNewswire

Mar. 16, 2026

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

GlobeNewswire

Mar. 16, 2026

Poison Prevention Week – Thinking beyond the Obvious

GlobeNewswire